These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33007024)

  • 1. The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
    Blázquez-Bermejo Z; Farré N; Llagostera M; Caravaca Perez P; Morán-Fernández L; Fort A; De-Juan J; Ruiz S; Delgado JF
    PLoS One; 2020; 15(10):e0240098. PubMed ID: 33007024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
    Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
    ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure.
    Scatularo CE; Battioni L; Guazzone A; Esperón G; Corsico L; Grancelli HO
    Curr Probl Cardiol; 2024 Aug; 49(8):102674. PubMed ID: 38795800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
    Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H
    Clin Res Cardiol; 2013 Oct; 102(10):745-53. PubMed ID: 23839288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and outcome of diuretic resistance in heart failure.
    Trullàs JC; Casado J; Morales-Rull JL; Formiga F; Conde-Martel A; Quirós R; Epelde F; González-Franco Á; Manzano L; Montero-Pérez-Barquero M
    Intern Emerg Med; 2019 Jun; 14(4):529-537. PubMed ID: 30610440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic resistance in acute heart failure: proposal for a new urinary sodium-based definition.
    Pellegrino M; Villaschi A; Gasparini G; Maccallini M; Pinto G; Pini D
    Int J Cardiol; 2024 Nov; 415():132456. PubMed ID: 39151483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure.
    Palazzuoli A; Ruocco G; Severino P; Gennari L; Pirrotta F; Stefanini A; Tramonte F; Feola M; Mancone M; Fedele F
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very Early Diuretic Response After Admission for Acute Heart Failure.
    Kuroda S; Damman K; Ter Maaten JM; Voors AA; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kitai T; Yoshida K; Matsumura A; Matsue Y
    J Card Fail; 2019 Jan; 25(1):12-19. PubMed ID: 30219549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure.
    Pellicori P; Cleland JG; Zhang J; Kallvikbacka-Bennett A; Urbinati A; Shah P; Kazmi S; Clark AL
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):599-609. PubMed ID: 27819111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
    Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
    Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
    da Rosa PR; Rohde LE; Doebber M; Ribeiro ALP; Prado DP; Bertoldi EG; Figueiredo Neto JA; Kohler I; Beck-da-Silva L; Danzmann LC; Moura LZ; Rover M; Simões MV; Sant'Anna RT; Biolo A
    Am Heart J; 2017 Dec; 194():125-131. PubMed ID: 29223430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
    Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
    Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic Fluid Content as an Indicator of High Intravenous Diuretic Requirements in Hospitalized Patients with Decompensated Heart Failure.
    Galas A; Krzesiński P; Banak M; Gielerak G
    J Clin Med; 2024 Sep; 13(18):. PubMed ID: 39337112
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
    Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
    Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of diuretic dose in chronic heart failure.
    Martins J; Lourenço P; Araújo JP; Mascarenhas J; Lopes R; Azevedo A; Bettencourt P
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):185-91. PubMed ID: 21335479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.